0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Surgery

Claude H. Organ Jr, MD; Richard J. Bold, MD
JAMA. 1996;275(23):1855-1857. doi:10.1001/jama.1996.03530470083050.
Text Size: A A A
Published online

Advances in the understanding of cancer at the molecular biology level have added prognostic information and possible therapeutic alternatives. The expression or absence of various oncogenes independently predict prognosis in various tumor types. Protein expression of the c-erb B2 oncogene is associated with a favorable therapeutic response and improved survival in esophageal adenocarcinoma.1 In breast cancer, the coexpression of several oncogenes (c-fos, c-myc, Ha-ras) endowed tumors with a more aggressive phenotype, leading to increased occurrence of invasive carcinoma and local recurrence while adversely affecting disease-free and overall survival.2 Multiple genetic mutations have been identified in the stepwise progression of the development of colorectal carcinoma. The loss of heterozygosity on chromosome 17p strongly correlates with lymphatic and/or vascular microinvasion and, therefore, is a negative prognostic indicator independent of cancer stage.3

The precise determination of the molecular events involved in the neoplastic transformation process may lead

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();